TANVEER, M.; AHSAN KAMAL. FDAs new approval: yeztugo (lenacapavir): a longer lasting avenue against HIV. Journal of the Pakistan Medical Association, [S. l.], v. 76, n. 8, p. 1401–1401, 2026. DOI: 10.47391/JPMA.33073. Disponível em: https://mail.jpma.org.pk/index.php/public_html/article/view/33073. Acesso em: 15 jul. 2026.